New cancer clinical trial: CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer

Published on: June 25, 2018 at 12:00PM
Condition:   Breast Cancer
Interventions:   Drug: CFI-402257;   Drug: Paclitaxel
Sponsors:   Canadian Cancer Trials Group;   Stand Up To Cancer;   Canadian Breast Cancer Foundation;   Ontario Institute for Cancer Research
Not yet recruiting
https://ift.tt/2KthIrS